Johann Sebastian De Bono
Observed names: Bono Johann S de, Bono Johann de, Bono, Johann De, Bono, Johann S De, De Bono, J, De Bono, J., De Bono, JS, De Bono, Johann S, De Bono, Johann S., J DEBONO, J De Bono, J De-Bono, J S De Bono, J S de Bono, J de Bono, J. Bono, J. De Bono, J. De bono, J. De-Bono, J. DeBono, J. S D. Bono, J. S. De Bono, J. S. DeBono, J. S. de Bono, J. Sebastian de Bono, J. de Bono, J. de-Bono, J.S. DE BONO, J.S. De Bono, J.S. De-Bono, J.S. De-bono, J.S. DeBono, J.S. de Bono, J.S. de-Bono, J.S. deBono, JS de Bono, Joahnn S. De Bono, Johan S. De Bono, Johan S. de Bono, Johan de Bono, Johann Bono, Johann De Bonno, Johann De Bono, Johann De Bono D, Johann De Bono Mbchb, Johann De-Bono, Johann DeBono, Johann De‐Bono, Johann S De Bono, Johann S De-Bono, Johann S de Bono, Johann S. Bono, Johann S. De Bono, Johann S. De Bono D, Johann S. De-Bono, Johann S. DeBono, Johann S. Debono, Johann S. de Bono, Johann S. deBono, Johann Sebastian de Bono, Johann Sebastian de Bono, Johann de Bono, Johann deBono, Johann. S. de Bono, JohannDe Bono, Johann S. de Bono, Js De Bono, S de Bono, de Bono, J, de Bono, JS, de Bono, Johann, de Bono, Johann S, de Bono, Johann S., de-Bono, JS
Observed institutions: Université Paris-Sud, Goethe University Frankfurt, Tulane University, University of Southern California, F. Hoffmann-La Roche AG, University of Bern, University of London, National Health Service, Queen's University Belfast, Translational Genomics Research Institute, Fox Chase Cancer Center, BC Cancer Agency, Brooke Army Medical Center, University College Hospital, Roswell Park Comprehensive Cancer Center, Cliniques Universitaires Saint-Luc, Beth Israel Deaconess Medical Center, The Royal Melbourne Hospital, St Thomas' Hospital, Royal Marsden NHS Foundation Trust, Mayo Clinic, Seattle Cancer Care Alliance, Nottingham University Hospitals NHS Trust, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Howard Hughes Medical Institute, Vrije Universiteit Brussel, University of Bonn, Janssen (Belgium), University of Arizona, Institute of Cancer Research, Johns Hopkins University, Radboud University Nijmegen, University of Liverpool, Thomas Jefferson University, Exelixis (United States), Imperial College Healthcare NHS Trust, Henry Ford Health, Inserm, University of California, Los Angeles, St George's, University of London, The University of Texas at San Antonio Health Science Center, Duke University, University of California, San Francisco, Pfizer (United States), King's College London, Lund University, Utrecht University, University of Aberdeen, National and Kapodistrian University of Athens, University of Washington, Cornell University, Aristotle University of Thessaloniki, Université Paris-Saclay, University of Michigan, Columbia University Irving Medical Center, Sheba Medical Center, Kantonsspital St. Gallen, Western General Hospital, Tulane Medical Center, Beatson West of Scotland Cancer Centre, Mount Vernon Hospital, University Hospital of Bern, Western Infirmary, Churchill Hospital, Cancer Research UK, St James's University Hospital, Odense University Hospital, Asan Medical Center, Royal Hallamshire Hospital, Hammersmith Hospital, Monklands Hospital, Jewish General Hospital, Institut Gustave Roussy, Freeman Hospital, Erasmus MC, Gartnavel General Hospital, Wellcome Sanger Institute, Edinburgh Cancer Research, Rigshospitalet, Yale Cancer Center, Stobhill Hospital, Belfast City Hospital, Radboud University Medical Center, University of Surrey, The Netherlands Cancer Institute, Sanofi (France), University Medical Center Utrecht, Moffitt Cancer Center, UNSW Sydney, University of Alabama at Birmingham, Yale University, University of Florida, Enzon Pharmaceuticals (United States), University of Oxford, University of Chicago, NYU Langone Health, Massachusetts General Hospital, Fred Hutch Cancer Center, Spanish National Cancer Research Centre, Housey Pharmaceutical Research Laboratories, Institute of Cancer Research, MRC Clinical Trials Unit at UCL, Ospedale "Santa Maria delle Croci" di Ravenna, Azienda Ospedaliera San Camillo-Forlanini, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Institut universitaire du cancer de Toulouse Oncopole, Hospital Universitario 12 De Octubre, Hôpital Européen Georges-Pompidou, University Hospital Münster, Centre Léon Bérard, Institut Català d'Oncologia, Hospital Regional Universitario de Málaga, Prince of Wales Hospital, Mount Vernon Cancer Centre, Istanbul University-Cerrahpaşa, Boehringer Ingelheim (United Kingdom), GlaxoSmithKline (United States), PharmaMar (Spain), USC Norris Comprehensive Cancer Center, Dana-Farber Cancer Institute, South Texas Accelerated Research Therapeutics, New York Oncology Hematology, Royal Marsden Hospital, HM Hospitales, Duke Medical Center, Duke-NUS Medical School, Cancer Research Center, Vall d'Hebron Hospital Universitari, Institut Claudius Regaud, The Christie Hospital, The Christie NHS Foundation Trust, Centre Hospitalier de l’Université de Montréal, Cancer Research UK Scotland Institute, Erasmus MC Cancer Institute, Institut Paoli-Calmettes, Velindre Cancer Centre, Carlo Forlanini Hospital, Royal Preston Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori, International Hereditary Cancer Center, Mount Vernon Hospital, Sidney Kimmel Comprehensive Cancer Center, Instituto de Investigación Biomédica de Málaga, UCSF Helen Diller Family Comprehensive Cancer Center, Weill Cornell Medicine, Vall d'Hebron Institute of Oncology, Université Paris Descartes, Indiana University Indianapolis, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Duke Cancer Institute, NIHR Biomedical Research Centre at The Royal Marsden and the ICR, Cross Cancer Institute, PMV Pharmaceuticals, Inc. (United States), Daniel den Hoed Kliniek, Sidney Kimmel Center for Prostate and Urologic Cancers, Takeda Oncology (United States), Weill Cornell Medical Center, Janssen Research & Development (United States), Heinrich Heine University Düsseldorf, University College London, University of Rostock, Imperial College London, McGill University, University of Virginia, Indiana University – Purdue University Indianapolis, New York University, Istanbul University, Université de Montréal, Freie Universität Berlin, Columbia University, Charité – Universitätsmedizin Berlin, University of Glasgow, Cardiff University, University of Birmingham, Institut Curie, The University of Texas Southwestern Medical Center, Oncolytics Biotech (Canada), Umeå University, BioMarin (United States), University of Twente, UCLouvain, Université de Reims Champagne-Ardenne, University of Edinburgh, KU Leuven
ORCID: 0000-0002-2034-595X
Observed ORCID: 0000-0002-2034-595X
OpenAlex ID: A5072378199
